{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:24:22Z","timestamp":1786994662881,"version":"build-2736575974"},"reference-count":40,"publisher":"Informa UK Limited","issue":"12","license":[{"start":{"date-parts":[[2021,12,2]],"date-time":"2021-12-02T00:00:00Z","timestamp":1638403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/doi.org\/10.1080\/policies-text-data-mining"}],"funder":[{"name":"no funding"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Human Vaccines &amp; Immunotherapeutics"],"published-print":{"date-parts":[[2021,12,2]]},"DOI":"10.1080\/21645515.2021.1985890","type":"journal-article","created":{"date-parts":[[2021,12,2]],"date-time":"2021-12-02T22:32:35Z","timestamp":1638484355000},"page":"5304-5310","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":21,"title":["Risk of Guillain-Barr\u00e9 syndrome following herpes zoster, United States, 2010\u20132018"],"prefix":"10.1080","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7222-1107","authenticated-orcid":false,"given":"Tara C.","family":"Anderson","sequence":"first","affiliation":[{"name":"Centers for Disease Control and Prevention","place":["Atlanta, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5164-7555","authenticated-orcid":false,"given":"Jessica W.","family":"Leung","sequence":"additional","affiliation":[{"name":"Centers for Disease Control and Prevention","place":["Atlanta, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1024-057X","authenticated-orcid":false,"given":"Rafael","family":"Harpaz","sequence":"additional","affiliation":[{"name":"Harpaz Herman Consultants, LLC","place":["Atlanta, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen L.","family":"Dooling","sequence":"additional","affiliation":[{"name":"Centers for Disease Control and Prevention","place":["Atlanta, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2021,12,2]]},"reference":[{"key":"e_1_3_5_2_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1525-1497.2005.0150.x"},{"issue":"5","key":"e_1_3_5_3_1","first-page":"1","article-title":"Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"57","author":"Harpaz R","year":"2008","unstructured":"Harpaz R, Ortega-Sanchez IR, Seward JF; Advisory Committee on Immunization Practices (ACIP). Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2008;57(RR\u20135):1\u201330.","journal-title":"MMWR Recomm Rep"},{"key":"e_1_3_5_4_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciy953"},{"key":"e_1_3_5_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2017.10.009"},{"key":"e_1_3_5_6_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciz1090"},{"key":"e_1_3_5_7_1","first-page":"1528","article-title":"Update on herpes zoster vaccine: licensure for persons aged 50 through 59 years","volume":"60","author":"Centers for Disease Control and Prevention","year":"2011","unstructured":"Centers for Disease Control and Prevention. Update on herpes zoster vaccine: licensure for persons aged 50 through 59 years. MMWR Morb Mortal Wkly Rep. 2011;60:1528.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"e_1_3_5_8_1","first-page":"729","article-title":"Update on recommendations for use of herpes zoster vaccine","volume":"63","author":"Hales CM","year":"2014","unstructured":"Hales CM, Harpaz R, Ortega-Sanchez I, Bialek SR. Update on recommendations for use of herpes zoster vaccine. MMWR Morb Mortal Wkly Rep. 2014;63:729\u201331.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"e_1_3_5_9_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6703a5"},{"key":"e_1_3_5_10_1","unstructured":"Food and Drug Administration. Shingrix US package insert Revised: 07\/2021. Silver Spring MD: US Department of Health and Human Services Food and Drug Administration; 2021. https:\/\/www.fda.gov\/media\/108597\/download."},{"key":"e_1_3_5_11_1","unstructured":"Anderson TC. Work Group interpretation of the Evidence to Recommendations Framework regarding use of RZV in immunocompromised adults considerations for use and proposed policy options. October 2021 Advisory Committee on Immunization Practices (ACIP) Meeting. 2021. https:\/\/www.cdc.gov\/vaccines\/acip\/meetings\/slides-2021-10-20-21.html."},{"key":"e_1_3_5_12_1","unstructured":"Centers for Disease Control & Prevention. What everyone should know about Zostavax. 2020 [accessed 2020 Dec 24]. https:\/\/www.cdc.gov\/vaccines\/vpd\/shingles\/public\/zostavax\/."},{"key":"e_1_3_5_13_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6804a4"},{"key":"e_1_3_5_14_1","volume-title":"October 2020 Advisory Committee on Immunization Practices (ACIP) Meeting","author":"Su JR","unstructured":"Su JR. Update on post-licensure safety monitoring of recombinant zoster vaccine (RZV, Shingrix). October 2020 Advisory Committee on Immunization Practices (ACIP) Meeting. 2020. https:\/\/www.cdc.gov\/vaccines\/acip\/meetings\/slides-2020-10.html."},{"key":"e_1_3_5_15_1","volume-title":"October 2020 Advisory Committee on Immunization Practices (ACIP) Meeting","author":"Nelson JC","unstructured":"Nelson JC. Vaccine Safety Datalink (VSD) update on post-licensure safety monitoring of recombinant zoster vaccine (RZV, Shingrix). October 2020 Advisory Committee on Immunization Practices (ACIP) Meeting. 2020. https:\/\/www.cdc.gov\/vaccines\/acip\/meetings\/slides-2020-10.html."},{"key":"e_1_3_5_16_1","volume-title":"June 2019 Advisory Committee on Immunization Practices (ACIP) Meeting","author":"Shimabukuro T","unstructured":"Shimabukuro T. Update on post-licensure safety monitoring of recombinant zoster vaccine (RZV, Shingrix). June 2019 Advisory Committee on Immunization Practices (ACIP) Meeting. 2019. https:\/\/www.cdc.gov\/vaccines\/acip\/meetings\/slides-2020-10.html."},{"key":"e_1_3_5_17_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2021.6227"},{"key":"e_1_3_5_18_1","doi-asserted-by":"publisher","DOI":"10.36648\/2171-6625.10.4.301"},{"key":"e_1_3_5_19_1","first-page":"S341","article-title":"A case of Guillain-Barr\u00e9 syndrome (GBS) following zoster vaccination","volume":"35","author":"Tripathi A","year":"2020","unstructured":"Tripathi A, Dharapak P, Laskova V. A case of Guillain-Barr\u00e9 syndrome (GBS) following zoster vaccination. J Gener Intern Med. 2020;35:S341\u201342.","journal-title":"J Gener Intern Med"},{"key":"e_1_3_5_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)67665-9"},{"key":"e_1_3_5_21_1","doi-asserted-by":"publisher","DOI":"10.1159\/000324710"},{"key":"e_1_3_5_22_1","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.1985.04060100035016"},{"key":"e_1_3_5_23_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.33.5.633"},{"key":"e_1_3_5_24_1","doi-asserted-by":"publisher","DOI":"10.1159\/000339248"},{"key":"e_1_3_5_25_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-019-04156-z"},{"key":"e_1_3_5_26_1","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-200932040-00005"},{"key":"e_1_3_5_27_1","doi-asserted-by":"publisher","DOI":"10.1159\/000184748"},{"key":"e_1_3_5_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)00339-1"},{"key":"e_1_3_5_29_1","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.13704.1"},{"key":"e_1_3_5_30_1","doi-asserted-by":"publisher","DOI":"10.1136\/pgmj.63.746.1087"},{"key":"e_1_3_5_31_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00314094"},{"key":"e_1_3_5_32_1","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine1962.29.397"},{"key":"e_1_3_5_33_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200101043440117"},{"key":"e_1_3_5_34_1","doi-asserted-by":"publisher","DOI":"10.1086\/655136"},{"key":"e_1_3_5_35_1","doi-asserted-by":"publisher","DOI":"10.2307\/2533328"},{"key":"e_1_3_5_36_1","doi-asserted-by":"publisher","DOI":"10.1017\/S0950268811001531"},{"key":"e_1_3_5_37_1","doi-asserted-by":"publisher","DOI":"10.1002\/pds.3451"},{"key":"e_1_3_5_38_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.i4515"},{"key":"e_1_3_5_39_1","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwu322"},{"key":"e_1_3_5_40_1","doi-asserted-by":"publisher","DOI":"10.1080\/10543406.2015.1052819"},{"key":"e_1_3_5_41_1","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2014-309056"}],"container-title":["Human Vaccines &amp; Immunotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/21645515.2021.1985890","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/full-xml\/10.1080\/21645515.2021.1985890","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/21645515.2021.1985890","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:25:19Z","timestamp":1786991119000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/21645515.2021.1985890"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,2]]},"references-count":40,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021,12,2]]}},"alternative-id":["10.1080\/21645515.2021.1985890"],"URL":"https:\/\/doi.org\/10.1080\/21645515.2021.1985890","relation":{},"ISSN":["2164-5515","2164-554X"],"issn-type":[{"value":"2164-5515","type":"print"},{"value":"2164-554X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,2]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=khvi20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=khvi20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2021-01-31","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-09-01","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-09-22","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-12-02","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}